Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
Bone , 03/21/2007
Robert R. Recker, et al. - In summary, as this trial was terminated early, there was insufficient power to compare the fracture risks between alendronate and raloxifene. Safety profiles were as expected from clinical trial and post-marketing reports







